Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quercetin Chemoprevention for Squamous Cell Carcinoma in Patients With Fanconi Anemia
NCT03476330Phase 2Completed
- Sponsor
- Cincinnati Children's Hospital Medical Center
- Start
- May 2018
- Primary completion
- Mar 2025
- Modality
- Allosteric Modulators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of quercetin in squamous cell carcinoma (SCC), sponsored by Cincinnati Children's Hospital Medical Center. Started May 2018; status: completed.
02
Drugs
quercetin
03
Conditions
squamous cell carcinoma (SCC)
Beyond the preview
Go deeper on NCT03476330.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03476330.